These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13604612)

  • 1. Some data in anti-cancer experiments.
    OKAMOTO H; KOSHIMURA S; HIRATA R; MURASAWA K; BANDO Y; SHIMIZU R
    Z Krebsforsch; 1958; 62(4):408-18. PubMed ID: 13604612
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal experimental studies of the anti-cancer chemotherapeutic agent, A-blastomase.
    ZINNITZ F; HAMMER O; HAMBSCH K; BILEK K
    Med Klin; 1959 Feb; 54(8):298-304. PubMed ID: 13643572
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer.
    Tortora G; Caputo R; Damiano V; Bianco R; Chen J; Agrawal S; Bianco AR; Ciardiello F
    Int J Cancer; 2000 Dec; 88(5):804-9. PubMed ID: 11072252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional differentiation of cytotoxic cancer drugs and targeted cancer therapeutics.
    Winkler GC; Barle EL; Galati G; Kluwe WM
    Regul Toxicol Pharmacol; 2014 Oct; 70(1):46-53. PubMed ID: 24956585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Targeted cytotoxic drugs emerging for cancer therapy].
    Junttila TT; Tanner M; Isola J
    Duodecim; 2011; 127(4):343-9. PubMed ID: 21442854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYMPOSIUM on anti-tumour agents: cytostatic agents.
    Proc R Soc Med; 1957 Jan; 50(1):1-6. PubMed ID: 13400844
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-cancer action of certain new phosphamides].
    CHERNOV VA; KROPACHEVA AA; SERGIEVSKAIA SI
    Farmakol Toksikol; 1956; 19(4):30-1. PubMed ID: 13375700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selection of anti-cancer antibiotics producing strains of Actinomyces].
    SOLOV'EVA NK; SEMENOVA VA; DELOVA ID; RUDAIA SM; IL'INSKAIA SA
    Antibiotiki (Mosc); 1958; 3(1):3-7. PubMed ID: 24544802
    [No Abstract]   [Full Text] [Related]  

  • 10. An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation.
    Yoshida S; Kawaguchi H; Sato S; Ueda R; Furukawa K
    Jpn J Cancer Res; 2002 Jul; 93(7):816-24. PubMed ID: 12149148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton.
    Hayot C; Farinelle S; De Decker R; Decaestecker C; Darro F; Kiss R; Van Damme M
    Int J Oncol; 2002 Aug; 21(2):417-25. PubMed ID: 12118340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity in human cell cultures as a primary screen for the detection of anti-tumor agents.
    EAGLE H; FOLEY GE
    Cancer Res; 1958 Oct; 18(9):1017-25. PubMed ID: 13596943
    [No Abstract]   [Full Text] [Related]  

  • 13. ANAESTHESIA FOR PERFUSION WITH CYTOTOXIC DRUGS IN CANCER OF THE HEAD AND NECK.
    CONDON HA
    Br J Anaesth; 1963 Jul; 35():438-40. PubMed ID: 14046137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Utilization of ascites carcinoma cultures in Petri dish in selection of organisms producing anti-cancer antibiotics].
    PAVLENKO Ia
    Antibiotiki (Mosc); 1958; 3(1):14-7. PubMed ID: 24544805
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-tumour activity of 5-mercaptouracil.
    BARDOS TJ; SEGALOFF A; AMBRUS JL
    Nature; 1959 Feb; 183(4661):613-4. PubMed ID: 13632812
    [No Abstract]   [Full Text] [Related]  

  • 16. Dosing Three-Drug Combinations That Include Targeted Anti-Cancer Agents: Analysis of 37,763 Patients.
    Nikanjam M; Liu S; Yang J; Kurzrock R
    Oncologist; 2017 May; 22(5):576-584. PubMed ID: 28424323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of polysaccharide cytotoxic drug conjugates for cancer therapy.
    Goodarzi N; Varshochian R; Kamalinia G; Atyabi F; Dinarvand R
    Carbohydr Polym; 2013 Feb; 92(2):1280-93. PubMed ID: 23399156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VASCULARIZATION OF TUMORS OF THE COLON AND RECTUM: WITH PARTICULAR REFERENCE TO DISSEMINATION OF CANCER CELLS THROUGH THE VENOUS SYSTEM AND THE RELATIONSHIP OF PERFUSION OR INFUSION OF CYTOTOXIC DRUGS TO THE BLOOD SUPPLY OF THESE TUMORS.
    GRIFFITH JD
    Dis Colon Rectum; 1965; 8():114-5. PubMed ID: 14275053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of cancer].
    ZUKERMAN C
    Cir Cir; 1957 Jul; 25(7):379-94. PubMed ID: 13473073
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual antagonists; alkyl N-(bis-(ethylenimido) phosphoro)-carbamates; a new series of anti-tumour agents.
    BARDOS TJ; PAPANASTASSIOU ZB; SEGALOFF A; AMBRUS JL
    Nature; 1959 Feb; 183(4658):399-400. PubMed ID: 13632736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.